Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management (Secret of CHF)
This study is currently recruiting participants.
Verified January 2013 by Cardiovascular Clinical Science Foundation
Study NCT01584557
Information provided by Cardiovascular Clinical Science Foundation
First Received on April 10, 2012.
Last Updated on January 30, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
